Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer (Q66395847)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer |
clinical trial |
Statements
A Phase II Study of Apatinib In Combination With Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer (English)
0 references
10 August 2016
0 references
31 December 2017
0 references
35
0 references
18 year
0 references
70 year
0 references